Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients

被引：0
|
作者：
Pinelli, Valentina
Fini, Donatella
Battolla, Enrico
Ferro, Paola
Franceschini, Maria Cristiana
Fontana, Vincenzo
Pistillo, Maria Pia
Roncella, Silvio
Canessa, Pier Aldo
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Mesothelioma; Pleura; Biomarkers;
D O I：
10.1183/13993003.congress-2016.PA5075
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA5075
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Malignant Pleural Mesothelioma Prognostic Marker: A Review of Osteopontin and Soluble Mesothelin Peptides
    Alaribe, Franca N.
    Maniero, Staffania
    Pancaldi, Cecilia
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2010, 9 (06) : 605 - 613
  • [32] Implantable Cytokine Factories for Eradication of Malignant Pleural Mesothelioma (MPM) Tumors in Mice
    Nash, A.
    Aghlara-Fotovat, S.
    Castillo, B.
    Hernandez, A.
    Pugazenthi, A.
    Jang, H-J.
    Lee, H-S.
    Burt, B.
    Ghanta, R.
    Veiseh, O.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S117 - S117
  • [33] LONG NON CODING RNAS (LNCRNAS) ARE DYSREGULATED IN MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Wright, Casey
    Kirschner, Michaela B.
    Cheng, Yuen Yee
    Byrne, Kenneth O.
    Gray, Steven
    Schelch, Karin
    Hoda, Mir Alireza
    Klebe, Sonja
    Mccaughan, Brian
    Van Zandwijk, Nico
    Reid, Glen
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S788 - S789
  • [34] Molecular and Pathological Features of Different Malignant Pleural Mesothelioma (MPM) Histologic Subtypes
    Pasello, Giulia
    Urso, Loredana
    Mencoboni, Manlio
    Grosso, Federica
    Ceresoli, Giovanni L.
    Lunardi, Francesca
    Bertorelle, Roberta
    Ciminale, Vincenzo
    Rea, Federico
    Favaretto, AdolfoG.
    Conte, Pierfranco
    Calabrese, Fiorella
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S351 - S351
  • [35] Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma An updated meta-analysis
    Gao, Ruiyue
    Wang, Feng
    Wang, Zhen
    Wu, Yanbing
    Xu, Lili
    Qin, Yue
    Shi, Huanzhong
    Tong, Zhaohui
    MEDICINE, 2019, 98 (14)
  • [36] Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma
    Bonotti, Alessandra
    Simonini, Silvia
    Pantani, Elena
    Giusti, Laura
    Donadio, Elena
    Mazzoni, Maria Rosa
    Chella, Antonio
    Marconi, Letizia
    Ambrosino, Nicolino
    Lucchi, Marco
    Mussi, Alfredo
    Cristaudo, Alfonso
    Foddis, Rudy
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (01) : E126 - E131
  • [37] Detection and Cultivation of Circulating Tumor Cells in Malignant Pleural Mesothelioma
    Bobek, Vladimir
    Kacprzak, Grzegorz
    Rzechonek, Adam
    Kolostova, Katarina
    ANTICANCER RESEARCH, 2014, 34 (05) : 2565 - 2569
  • [38] Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
    Klampatsa, Astero
    Haas, Andrew R.
    Moon, Edmund K.
    Albelda, Steven M.
    CANCERS, 2017, 9 (09):
  • [39] Prognostic value of midkine, syndecan-1, hyaluronan synthase-2, sestrin-1, laminin subunit alpha-4 and fibulin-3 for malignant pleural mesothelioma
    Akgun, Hakan
    Metintas, Selma
    Ak, Guntulu
    Canli, Secil Demirkol
    Isbilen, Murat
    Gure, Ali O.
    Metintas, Muzaffer
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (02) : 355 - 364
  • [40] ASSESSING SURVIVAL AND TIME TO TREATMENT (TT) FOR PATIENTS DIAGNOSED WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN ONTARIO, CANADA.
    Hasani, Arman
    Sun, Bin
    Liu, Geoffrey
    Xu, Wei
    Feld, Ronald
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S536 - S537
12345